March 30 (Reuters) – Valeant Pharmaceuticals International Inc said it had asked its lenders to agree to waive a condition of its credit facility that would put it in breach of covenants if the…
The post Valeant seeks waiver from lenders related to filing annual report appeared first on NASDAQ.